- The world has started reimposing tough SOPs to curb the surging infections.
- Scientists warned that Omicron is highly contagious.
- France and the UK have recorded all-time high infections since 2020.
PARIS: European nations reimposed tough rules and China locked down millions on Thursday, as countries scrambled to contain surging coronavirus infections driven by the Omicron variant.
The UK said the risk of hospitalisation was as much as 70 percent lower among people infected with Omicron compared to the previously dominant Delta strain, echoing studies published Wednesday in England and Scotland.
But scientists have warned that Omicron is highly contagious and could still lead to more overall severe cases.
France and the United Kingdom on Thursday announced all-time records of Covid-19 daily infections since the start of the pandemic in early 2020.
As families across Europe prepared for Christmas, governments announced a raft of new measures to prevent intensified spread of the new strain, putting a dampener on festivities.
Spain’s Catalonia was to reimpose a night-time curfew for a fortnight from Christmas Eve, while Scotland announced it would close nightclubs from next week, including on New Year’s Eve.
Europe has been hit hard by the ongoing surge, recording 60 percent of global cases over the past week, according to an AFP tally from official sources on Wednesday.
In other new measures Thursday, Greece said people must wear face masks both indoors and outside during Christmas and New Year’s gatherings.
Denmark asked all foreigners — even those vaccinated — to show a negative Covid test to be able to enter the country.
– 13 million indoors –
Reacting with more stringency, China shut down a city of 13 million people on Thursday in a bid to extinguish a tiny Covid-19 outbreak and chase its zero-case goal.
China locked down the northern city of Xi’an — home to the world-famous Terracotta Warriors — to stamp out a cluster of several hundred cases.
“I think it is necessary to have the lockdown,” said a Xi’an resident, who wanted to be identified only as Yuan.
Omicron has not been reported in Xi’an, with only dozens of cases of the less infectious Delta variant detected in the city of 13 million people in recent days.
But the Chinese government, in pursuit of its zero-case strategy ahead of the Beijing Winter Olympics, has ordered all Xi’an residents to stay indoors.
Only one person per household can go outside every two days to buy necessities, while non-essential businesses are closed.
February’s Olympics are set to be the most restrictive mass sporting event since the pandemic began, with international spectators banned and all participants required to stay inside a closed-loop system.
– Covid pills –
In business, German national carrier Lufthansa said Omicron forced it to axe 33,000 flights following a drop in bookings.
Denmark discovered an illegal mink farm that had been operating despite a ban, after the country last year culled millions of the animals over fears they could carry coronavirus and jeopardise vaccine effectiveness.
But in some positive news, the US Food and Drug Administration authorised Merck’s Covid pill for high-risk adults, a day after giving the green light to a similar Pfizer product.
The pill developed by Merck is taken within five days of symptom onset.
It has been shown to reduce Covid hospitalisations and deaths by 30 percent among at-risk people, whereas Pfizer’s pill reduced the same outcomes by almost 90 percent.
Pills that are available at pharmacies are likely to be much easier to access than synthetic antibody treatments, which require infusions at hospitals or specialised centres.
The United States has spent $5.3 billion (4.68 billion euros) procuring 10 million courses of the Pfizer treatment, according to the White House.
But health authorities maintain that vaccines are still the best protection against any variant, and are encouraging booster shots.
AstraZeneca said Thursday that a third dose of its Covid-19 vaccine “significantly” lifted antibody levels against the Omicron strain in a laboratory study.